anti-neutrophil, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, anti-neutrophil

Abad E, Tural C, Mirapeix E, Cuxart A 1997 Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. J. Autoimmun. 10: 175-180. *
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M 2006 Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin. Exp. Immunol. 145: 63-70. *
Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, Garrity J, Goeken JA, Allen NB 2002 Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J. Rheumatol. 29: 309-316.
Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG 2008 Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 58: 2196-2205. *
Abreu MT 2002 The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489.
Achkar JP, Barmada MM, Duerr RH 2002 Perinuclear neutrophil antibodies are not markers for genetic susceptibility or indicators of genetic heterogeneity in familial ulcerative colitis. Am. J. Gastroenterol. 97: 2343-2349. *
Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A 2006 Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect. Immun. 74: 4708-4714. *
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB 2004 Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441. *
Aisenberg J, Wagreich J, Shim J, Almer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N, et al 1995 Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig. Dis. Sci. 40: 1866-1872.
Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E 1995 Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J. Clin. Pathol. 48: 645-647. *
Akahoshi M, Yoshimoto G, Nakashima H, Miyake K, Inoue Y, Tanaka Y, Tsukamoto H, Horiuchi T, Otsuka T, Harada M 2004 MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod. Rheumatol. 14: 179-183.
Akamizu T, Ozaki S, Hiratani H, Uesugi H, Sobajima J, Hataya Y, Kanamoto N, Saijo M, Hattori Y, Moriyama K, Ohmori K, Nakao K 2002 Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin. Exp. Immunol. 127: 92-98. *
Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED 2007 Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum. 57: 837-844. *
Al-Mutawa SA, Hegab SM 2004 Behcet's disease. Clin. Exp. Med. 4: 103-131. *
Alcorta DA, Barnes DA, Dooley MA, Sullivan P, Jonas B, Liu Y, Lionaki S, Reddy CB, Chin H, Dempsey AA, Jennette JC, Falk RJ 2007 Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int. 72: 853-864.
Aldred PM, Hollox EJ, Armour JA 2005 Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum. Mol. Genet. 14: 2045-2052. *
Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F 2004 Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am. J. Vet. Res. 65: 1279-1283.
Alonso-Llamazares J, Gibson LE, Rogers RS 3rd 2007 Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int. J. Dermatol. 46: 910-919. *
Amati L, Caradonna L, Jirillo E, Caccavo D 1999 Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital. J. Gastroenterol. Hepatol. 31: 313-325.
Amati L, Caradonna L, Leandro G, Magrone T, Minenna M, Faleo G, Pellegrino NM, Jirillo E, Caccavo D 2003 Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Design 9: 1937-1945.
Amigo M, Paya M, De Rosa S, Terencio MC 2007 Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin. Br. J. Pharmacol. 152: 353-365. *
Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF 2006 Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin. Vaccine Immunol. 13: 289-296. *
Ammon HP 2006 Boswellic acids in chronic inflammatory diseases. Planta Med. 72: 1100-1116.
Amre DK, Lu SE, Costea F, Seidman EG 2006 Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 101: 645-652. *
Anand V, Russell AS, Tsuyuki R, Fedorak R 2008 Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can. J. Gastroenterol. 22: 33-36.
Anderson P, Phillips K, Stoecklin G, Kedersha N 2004 Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76: 42-47. *
Andersson E, Axelsson J, Pedersen LC, Elm T, Andersson R 2007 Treatment with anti-factor VIIa in acute pancreatitis in rats: blocking both coagulation and inflammation? Scand. J. Gastroenterol. 42: 765-770. *
Andre MF, Piette JC, Kemeny JL, Ninet J, Jego P, Delevaux I, Wechsler B, Weiller PJ, Frances C, Bletry O, Wismans PJ, Rousset H, Colombel JF, Aumaitre O; and the French Study Group on Aseptic Abscesses 2007 Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore) 86: 145-161.
Andreani ML, Frasca G, Brusco G, Borgnino L, Biagi F, Gasbarrini G, Corazza GR 1996 Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?. Ann. Ital. Med. Int. 11: 254-257.
Andrews T, Sullivan KE 2003 Infections in patients with inherited defects in phagocytic function. Clin. Microbiol. Rev. 16: 597-621. *
Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY 2002 Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 17: 908-913. *
Angriman I, Scarpa M, D'Inca R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D'Amico DF, Plebani M 2007 Enzymes in feces: useful markers of chronic inflammatory bowel disease. Clin. Chim. Acta 381: 63-68. *
Angulo JM, Sigal LH, Espinoza LR 1998 Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin. Arthritis Rheum. 28: 187-192. *
Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD 2000 Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 32: 182-187. *
Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A 2005 Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study. Am. J. Gastroenterol. 100: 84-92. *
Annese V, Piepoli A, Andriulli A, Napolitano G, Bisceglia L, Zelante L, Gasparini P 1998 Polymorphism of motilin gene in patients with Crohn's disease. Dig. Dis. Sci. 43: 715-719. *
Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N, Cocchiara E, Accadia L, Perri F, Andriulli A 2005 HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis. Colon Rectum 48: 57-64.
Anthoni M, Fyhrquist-Vanni N, Wolff H, Alenius H, Lauerma A 2008 Transforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity. Br. J. Dermatol. Jun 27 [Epub ahead of print]. *
Antille C, Frei M, Sorg O, Tran C, Kaya G, Masouye I, Fontao L, Prins C, Saurat JH 2008 Amicrobial pustulosis of the folds associated with auto-immune disorders. A case report with an analysis of cytokine expression profile in skin lesions of cutaneous neutrophilic lupus. Dermatology 216: 324-329.
Antoniu SA 2007 Treatment options for refractory Wegener's granulomatosis: a role for rituximab? Curr. Opin. Investig. Drugs 8: 927-932.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK 2005 Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol. Appl. Pharmacol. 207: 25-38. *
Ara J, Mirapeix E, Rodriguez R, Pascual J, Alvarez L, Darnell A 1998 Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis. Med. Clin. (Barc.) 111: 536-568.
Ardiles LG, Valderrama G, Moya P, Mezzano SA 1997 Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin. Nephrol. 47: 1-5.
Aries PM, Hellmich B, Gross WL 2005 Intravenous immunoglobulin therapy in vasculitis: speculation or evidence? Clin. Rev. Allergy Immunol. 29: 237-246.
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H 2007 The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int. J. Mol. Med. 19: 143-148. *
Arita M, Oh S, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, Serhan CN 2006 Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 281: 22847-22854. *
Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH 1988 Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 43: 84-92. *
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J 2004 Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99: 2376-2384. *
Aronoff DM, Serezani CH, Carstens JK, Marshall T, Gangireddy SR, Peters-Golden M, Reddy RC 2007 Stimulatory effects of peroxisome proliferator-activated receptor-gamma on Fcgamma receptor-mediated phagocytosis by alveolar macrophages. PPAR Res. 2007: 52546. *
Arranz O, Ara J, Rodriguez R, Quinto L, Font J, Mirapeix E, Darnell A 2001 Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Clin. Nephrol. 56: 295-301.
Arundel C, Lewis JH 2007 Drug-induced liver disease in 2006. Curr. Opin. Gastroenterol. 23: 244-254.
Asakura H, Sugimura K 1995 HLA, antineutrophil cytoplasmic autoantibody, and heterogeneity in ulcerative colitis. Gastroenterology 108: 597-599. *
Ashok D, Dubey S, Tomlinson I 2008 C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab. Clin. Rheumatol. 27: 261-264. *
Asquith DL, McInnes IB 2007 Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 19: 246-251.
Assi LK, Wong SH, Ludwig A, Raza K, Gordon C, Salmon M, Lord JM, Scheel-Toellner D 2007 Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthritis Rheum. 56: 1776-1786. *
Aubart FC, Ouayoun M, Brauner M, Attali P, Kambouchner M, Valeyre D, Nunes H 2006 Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) 85: 365-371.
Auci D, Nicoletti F, Mangano K, Pieters R, Nierkens S, Morgan L, Offner H, Frincke J, Reading C 2005 Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases. Ann. N. Y. Acad. Sci. 1051: 730-742.
Audrain MA, Gourbil A, Muller JY, Esnault LM 1996 Anti-lactoferrin autoantibodies: relation between epitopes and iron-binding domain. J. Autoimmun. 9: 569-574.
Audrain MA, Sesboue R, Baranger TA, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL 2001 Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol. Dial. Transplant. 16: 39-44. *
Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H 2003 Is agranulocytosis following infectious mononucleosis caused by autoimmunity? Pediatr. Hematol. Oncol. 20: 611-615.
Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, Megraud F 2003 Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect. Immun. 71: 3667-3672. *
Avnon LS, Abu-Shakra M, Flusser D, Heimer D, Sion-Vardy N 2007 Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate? Rheumatol. Int. 27: 919-925. *
Ayala de la Cruz Mdel C, Gonzalez Diaz R, Lopez Lara ND 2003 Wegener's granulomatosis. Report of a pediatric case and review of the literature. Rev. Alerg. Mex. 50: 71-75.
Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr 2003 Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 100: 3031-3034. *
Bacon PA 1991 Vasculitic syndromes associated with other rheumatic conditions and unclassified systemic vasculitis. Curr. Opin. Rheumatol. 3: 56-61.
Badakere SS, Pradhan VD, Almeida AF, Pawar AR 2004 Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. J. Fluoresc. 14: 459-463. *
Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ 1999 Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116: 22-28. *
Bajt ML, Ho YS, Vonderfecht SL, Jaeschke H 2002 Reactive oxygen as modulator of TNF and Fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxid. Redox Signal. 4: 733-740.
Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TC 3rd 2008 Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar. J. 7: 41.
Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, Tinaztepe K 2001 The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch. Dis. Child. 85: 427-430. *
Bakker-Jonges LE, ter Borg PC, van Buuren HR, Hooijkaas H 2006 A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis. Ned. Tijdschr. Geneeskd. 150: 490-494.
Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA 2004 Hearing loss in Wegener's granulomatosis. Otol. Neurotol. 25: 833-837.
Ballester I, Gonzalez R, Nieto A, Zarzuelo A, Sanchez de Medina F 2005 Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci. 76: 2965-2980. *
Ballieux BE, Hagen EC, van der Keur C, Zegers ND, van Es LA, van der Woude FJ, Daha MR 1993 Isolation of a protein complex from purulent sputum consisting of proteinase-3 and alpha 1-antitrypsin reactive with anti neutrophil cytoplasmic antibodies. J. Immunol. Methods 159: 63-70.
Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN 2005 Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355. *
Bansal AS, Thomson A, Steadman C, Le Gros G, Hogan PG, Kerlin P, Lynch S, Strong R 1997 Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. Autoimmunity 26: 223-229.
Bansi D, Chapman R, Fleming K 1996 Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J. Hepatol. 24: 581-586. *
Bansi DS, Bauducci M, Bergquist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E 1997 Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques. Eur. J. Gastroenterol. Hepatol. 9: 575-580.
Bansi DS, Chapman RW, Fleming KA 1996 Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8: 881-885.
Bansi DS, Fleming KA, Chapman RW 1996 Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 38: 384-389. *
Bansi DS, Fleming KA, Chapman RW 1995 Antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gastroenterology 109: 2049-2050. *
Bansi DS, Lo S, Chapman RW, Fleming KA 1996 Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 111-116.
Barsante MM, Cunha TM, Allegretti M, Cattani F, Policani F, Bizzarri C, Tafuri WL, Poole S, Cunha FQ, Bertini R, Teixeira MM 2008 Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br. J. Pharmacol. 153: 992-1002. *
Barta Z, Csipo I, Szabo GG, Szegedi G 2003 Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J. Gastroenterol. 9: 2308-2312. *
Barton CC, Ganey PE, Roth RA 2000 Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms. Toxicol. Sci. 58: 208-215. *
Bartunkova J, Kolarova I, Sediva A, Holzelova E 2002 Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin. Immunol. 102: 162-168. *
Bartunkova J, Tesar V, Sediva A 2003 Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin. Immunol. 106: 73-82. *
Baskol M, Baskol G, Kocer D, Ozbakir O, Yucesoy M 2008 Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis. J. Clin. Gastroenterol. 42: 687-691.
Baslund B, Petersen J, Permin H, Wiik A, Wieslander J 1994 Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J. Immunol. Methods 175: 215-225.
Basu D, Lopez I, Kulkarni A, Sellin JH 2005 Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 100: 2254-2261. *
Bataller R, Brenner DA 2001 Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21: 437-451.
Beaudreuil S, Lasfargues G, Laueriere L, Ghoul ZE, Fourquet F, Longuet C, Halimi JM, Nivet H, Buchler M 2005 Occupational exposure in ANCA-positive patients: a case-control study. Kidney Int. 67: 1961-1966.
Beaulieu J, Dupont C, Lemieux P 2007 Anti-inflammatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria in an atopic dermatitis model. J. Inflamm. (Lond.) 4: 6. *
Beaven SW, Abreu MT 2004 Biomarkers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 318-327.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC 2006 Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 24: 2283-2289. *
Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M 2006 Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides. Clin. Rheumatol. 25: 368-372. *
Belmont HM 2006 Treatment of ANCA-associated systemic vasculitis. Bull. Hosp. Jt. Dis. 64: 60-66. *
Bengmark S, Gil A 2006 Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr. Hosp. 21 Suppl. 2: 72-84, 73-86.
Bennink RJ, Hamann J, de Bruin K, Ten Kate FJ, van Deventer SJ, Te Velde AA 2005 Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis. J. Nucl. Med. 46: 526-531. *
Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M 2004 Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br. J. Dermatol. 150: 1009-1012. *
Berg PA, Klein R 2002 Autoimmune hepatitis and overlap syndrome: diagnosis. Schweiz. Rundsch. Med. Prax. 91: 1339-1346.
Berger-Achituv S, Ellis MH, Curtis BR, Wolach B 2008 Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent. Am. J. Hematol. 83: 676-678. *
Berlie I, Leboucher B, Leblanc M, Troussier F, Pellier I, Chevailler A, Ginies JL 2005 Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance. Arch. Pediatr. 12: 140-143.
Bernstein CN, Pettigrew NM, el-Gabalawy HS, Sargent M, Meu Y, Wilkins J 1996 The differential expression of a novel intestinal epithelial glycoprotein in various forms of inflammatory bowel disease. Am. J. Clin. Pathol. 106: 42-51.
Bertolini A, Ottani A, Sandrini M 2002 Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 9: 1033-1043.
Bezerra MM, Brain SD, Girao VC, Greenacre S, Keeble J, Rocha FA 2007 Neutrophils-derived peroxynitrite contributes to acute hyperalgesia and cell influx in zymosan arthritis. Naunyn. Schmiedebergs. Arch. Pharmacol. 374: 265-273.
Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A 2000 Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis. Int. Rev. Immunol. 19: 123-138.
Bigbee CL, Gonchoroff DG, Vratsanos G, Nadler SG, Haggerty HG, Flynn JL 2007 Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice. Arthritis Rheum. 56: 2557-2565. *
Bilgic S, Aktas E, Salman F, Ersahin G, Erten G, Yilmaz MT, Deniz G 2008 Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes. Diabetes Res. Clin. Pract. 79: 31-36.
Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S, Vidrich A 1995 Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am. J. Pathol. 147: 979-987. *
Bilu Martin D, Deng A, Gaspari A, Pearson F 2006 Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole. Skinmed. 5: 302-305.
Binder V, Orholm M 1996 Familial occurrence and inheritance studies in inflammatory bowel disease. Neth. J. Med. 48: 53-56.
Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C 2006 Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7: 284-292. *
Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS 1996 Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110.
Birrell MA, Catley MC, Hardaker E, Wong S, Willson TM, McCluskie K, Leonard T, Farrow SN, Collins JL, Haj-Yahia S, Belvisi MG 2007 Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. J. Biol. Chem. 282: 31882-31890. *
Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M 2008 Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16: 2-10.
Blackwell NM, Sembi P, Newson JS, Lawrence T, Gilroy DW, Kabouridis PS 2004 Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum. 50: 2675-2684. *
Blockmans D, Stevens E, Marien G, Bobbaers H 1998 Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia? Ann. Rheum. Dis. 57: 141-145. *
Bocker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol S, B Sartor R, Singer MV 2003 Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin. Exp. Immunol. 131: 53-60. *
Bogdanos D, Vergani D, Mieli-Vergani G 2004 Overlap syndromes from pediatrics to adulthood. J. Gastroenterol. Hepatol. 19: S284-S286. *
Bogdanos DP, Invernizzi P, Mackay IR, Vergani D 2008 Autoimmune liver serology: current diagnostic and clinical challenges. World J. Gastroenterol. 14: 3374-3387. *
Bokarewa MI, Jin T, Tarkowski A 2003 Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J. Rheumatol. 30: 1719-1724.
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M 2005 Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 7: R1072-R1081. *
Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW 2000 Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 43: 2025-2033. *
Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D 2004 Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 15: 717-721. *
Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB 2004 Infliximab improves endothelial dysfunction in systemic vasculitis. A model of vascular inflammation. Circulation 109: 1718-1723. *
Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB 2004 Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 50: 581-588. *
Borgmann S, Haubitz M 2004 Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 22 (6 Suppl. 36): S79-S86.
Bos JD, de Rie MA, Teunissen MB, Piskin G 2005 Psoriasis: dysregulation of innate immunity. Br. J. Dermatol. 152: 1098-1107. *
Bosch X, Guilabert A, Espinosa G, Mirapeix E 2008 Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Trends Immunol. 29: 280-289. *
Bosch X, Guilabert A, Font J 2006 Antineutrophil cytoplasmic antibodies. Lancet 368: 404-418. *
Bossuyt X 2006 Serologic markers in inflammatory bowel disease. Clin. Chem. 52: 171-181. *
Bouhnik Y 2005 Diagnostic tools in inflammatory bowel diseases. Rev. Prat. 55: 977-983.
Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS 1996 Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103: 391-396. *
Bourne T, Fossati G, Nesbitt A 2008 A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action. BioDrugs 22: 331-337.
Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, Jewell DP, Kon OM, Smith J, Rose M, Newman-Taylor AJ, Cole P, Wilson R, Altmann DM 2006 IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 68: 325-330. *
Brachemi S, Mambole A, Fakhouri F, Mouthon L, Guillevin L, Lesavre P, Halbwachs-Mecarelli L 2007 Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti-proteinase 3 antibodies. J. Am. Soc. Nephrol. 18: 2330-2339.
Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ 2006 Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre. Intern. Med. J. 36: 355-361. *
Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Balloum M, Qu K, Herlaar E, Lau A, Young C, Wong BR, Lovell S, Sun T, Park G, Argade A, Jurcevic S, Pine P, Singh R, Grossbard EB, Payan DG, Masuda ES 2006 R406, an orally svailable Syk kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 319: 998-1008. *
Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, Macek M Jr, Bartunkova J, Lauschmann H 2006 Differential cytokine profile in children with cystic fibrosis. Clin. Immunol. 115: 210-215. *
Breslin NP, Todd A, Kilgallen C, O'Morain C 1997 Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut 41: 557-560. *
Brett PM, Yasuda N, Yiannakou JY, Herbst F, Ellis HJ, Vaughan R, Nicholls RJ, Ciclitira PJ 1996 Genetic and immunological markers in pouchitis. Eur. J. Gastroenterol. Hepatol. 8: 951-955.
Brimnes J, Nielsen OH, Wiik A, Heegaard NH 1999 Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis. Dig. Dis. Sci. 44: 415-423. *
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A 2004 Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535. *
Brodsky B, Erlanger-Rosengarten A, Proscura E, Shapira E, Wormser U 2008 From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide. Toxicol. Appl. Pharmacol. 229: 342-350. *
Broekroelofs J, Mulder AH, Nelis GF, Westerveld BD, Tervaert JW, Kallenberg CG 1994 Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig. Dis. Sci. 39: 545-549.
Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO 1996 IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin. Exp. Immunol. 106: 273-279. *
Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG 1991 Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin. Exp. Immunol. 83: 379-386. *
Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG 2007 Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J. Am. Soc. Nephrol. 18: 1732-1739.
Brown SJ, Mayer L 2007 The immune response in inflammatory bowel disease. Am. J. Gastroenterol. 102: 2058-2069. *
Brownlee AA, Lockwood CM 1999 Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI). Clin. Exp. Immunol. 117: 183-189. *
Brunkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM 2000 Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med. 26 Suppl. 2: S199-S201.
Bruschi F 1997 Modulation of inflammatory cells in helminth infections. Ann. Ist Super. Sanita. 33: 541-549.
Buckland MS, Mylonaki M, Rampton D, Longhurst HJ 2005 Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation. Clin. Diagn. Lab. Immunol. 12: 1328-1330. *
Bueno de Mesquita M, Ferrante M, Henckaerts L, Joossens M, Janssens V, Hlavaty T, Pierik M, Joossens S, Van Schuerbeek N, Van Assche G, Rutgeerts P, Vermeire S, Hoffman I 2008 Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. Eur. J. Pediatr. Aug 1 [Epub ahead of print]. *
Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL 2006 IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7: 135. *
Bulois P, Tremaine WJ, Maunoury V, Gambiez L, Hafraoui S, Leteurtre L, Cortot A, Sandborn WJ, Colombel JF, Desreumaux P 2000 Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm. Bowel Dis. 6: 157-164. *
Bunch DO, Silver JS, Majure MC, Sullivan P, Alcorta DA, Chin H, Hogan SL, Lindstrom YI, Clarke SH, Falk RJ, Nachman PH 2008 Maintenance of tolerance by regulation of anti-myeloperoxidase B cells. J. Am. Soc. Nephrol. 19: 1763-1773.
Buning C, Schmidt HH, Molnar T, DE Jong DJ, Fiedler T, Buhner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Buttner J, Lochs H, Witt H 2007 Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment. Pharmacol. Ther. 26: 1025-1033. *
Burleson GR, Burleson FG 2008 Testing human biologicals in animal host resistance models. J. Immunotoxicol. 5: 23-31.
Burrows NP, Zhao MH, Norris PG, Lockwood CM 1996 ANCA associated with Behcet's disease. J. R. Soc. Med. 89: 47P-48P. *
Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P, Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S, Villa M, Burns WH 1998 Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 92: 3505-3514. *
Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N 2006 Autoantibodies in Argentine women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 55: 201-207.
Bux J 2008 Human neutrophil alloantigens. Vox. Sang. 94: 277-285.
Cabanillas M, Perez-Perez L, Sanchez-Aguilar D, Toribio J 2006 Generalized pustular psoriasis and cytolytic hepatitis associated with neutrophilic cholangitis. Actas. Dermosifiliogr. 97: 330-333.
Cabral VL, Miszputen SJ, Catapani WR 2003 Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology 50: 412-415.
Caccavo D, Afeltra A, Guido F, Di Monaco C, Ferri GM, Amoroso A, Vaccaro F, Bonomo L 1996 Two spatially distant epitopes of human lactoferrin. Hybridoma 15: 263-269.
Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A 2005 Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin. Rheumatol. 24: 381-387. *
Caicedo RA, Li N, DES Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, Schatz DA, Atkinson MA, Neu J 2008 Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatr. Res. 63: 303-307.
Calder PC 1998 Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz. J. Med. Biol. Res. 31: 467-490. *
Calvo Romero JM, Romero Requena J, Arevalo Lorido JC, Ramos Salado JL, Doblare Castellano E, Vargas Perez ML, Bureo Dacal P, Perez Miranda M 2002 Antineutrophil cytoplasmic antibodies (ANCA): clinico-pathologic correlations in a series of 82 cases. An. Med. Interna 19: 7-10.
Camara B, Kamar N, Bonafe JL, Danjoux M, Suc B, Rostaing L 2007 Syphilis-related hepatitis in a liver transplant patient. Exp. Clin. Transplant. 5: 724-726.
Camara B, Kamar N, Bonafe JL, Danjoux M, Suc B, Rostaing L 2007 Syphilis hepatitis and liver transplantation. Med. Mal. Infect. 37: 121-123.
Cambridge G, Rampton DS, Stevens TR, McCarthy DA, Kamm M, Leaker B 1992 Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 33: 668-674. *
Camelier AA, Winter DH, Jardim JR, Barboza CE, Cukier A, Miravitlles M 2008 Alpha-1 antitrypsin deficiency: diagnosis and treatment. J. Bras. Pneumol. 34: 514-527.
Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan SP 2007 Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21: 3162-3170. *
Canny G, Cario E, Lennartsson A, Gullberg U, Brennan C, Levy O, Colgan SP 2006 Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G557-G567. *
Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP 2002 Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. U.S.A. 99: 3902-3907. *
Canny G, Swidsinski A, McCormick BA 2006 Interactions of intestinal epithelial cells with bacteria and immune cells: methods to characterize microflora and functional consequences. Methods Mol. Biol. 341: 17-35.
Cantin AM, Berthiaume Y, Cloutier D, Martel M 2006 Prolastin aerosol therapy and sputum taurine in cystic fibrosis. Clin. Invest. Med. 29: 201-207.
Cao Y, Brombacher F, Tunyogi-Csapo M, Glant TT, Finnegan A 2007 Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum. 56: 861-870. *
Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P 2006 The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br. J. Dermatol. 154: 319-324. *
Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A 2007 The synthetic melanocortin (CKPV)(2) exerts broad anti-inflammatory effects in human neutrophils. Peptides 28: 2016-2022. *
Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M 2005 Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res. Ther. 7: R250-R255. *
Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D 2000 Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am. J. Gastroenterol. 95: 1495-1502. *
Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM 2006 Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol. Int. 26: 209-214. *
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E 2006 Systemic autoimmune disease in patients with uveitis. Arch. Soc. Esp. Oftalmol. 81: 193-198.
Carlson JA, Chen KR 2007 Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am. J. Dermatopathol. 29: 32-43.
Carmona E, Perez-Aguilar F, Lopez JA, Ferrer-Calvete J, Sanchez-Cuenca JM 2002 Anti-neutrophil-cytoplasmic auto-antibodies (ANCA) in 105 patients (56 adults and 49 children) suffering from cystic fibrosis, attending a Spanish hospital. J. Intern. Med. 252: 281-282. *
Caroselli C, Plocco M, Prattic X00f2 F, Bruno C, Antonaglia C, Rota F, Curreli I, Caroselli A, Bruno G 2007 Ulcerative colitis masked by giant urticaria. Int. J. Immunopathol. Pharmacol. 20: 181-184.
Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N 2004 Painful sensory neuropathy and dysimmunity: is there a relation? J. Peripher. Nerv. Syst. 9: 121.
Carroll IM, Andrus JM, Bruno-Barcena JM, Klaenhammer TR, Hassan HM, Threadgill DS 2007 The anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase (MnSOD) using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G729-G738. *
Caruso R, Fina D, Paoluzi OA, Del Vecchio Blanco G, Stolfi C, Rizzo A, Caprioli F, Sarra M, Andrei F, Fantini MC, Macdonald TT, Pallone F, Monteleone G 2008 IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 38: 470-478. *
Cassatella MA 2006 On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J. Leukoc. Biol. 79: 1140-1149. *
Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, Borghesio E, Bessone MP, Astegiano M, Musso A, et al 1995 Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Eur. J. Gastroenterol. Hepatol. 7: 859-864.
Castro-Santos P, Suarez A, Mozo L, Gutierrez C 2007 Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis. Clin. Immunol. 122: 108-114. *
Catarzi S, Marcucci T, Papucci L, Favilli F, Donnini M, Tonelli F, Vincenzini MT, Iantomasi T 2008 Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease patients. Inflamm. Bowel Dis. 14: 819-825.
Cawood AL, Carroll MP, Wootton SA, Calder PC 2005 Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159.
Cazanave S, Vadrot N, Tinel M, Berson A, Lett�ron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D 2008 Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. Toxicol. Appl. Pharmacol. 231: 336-343.
Cecere A, Tancredi L, Gattoni A 2002 Primary sclerosing cholangitis. Panminerva Med. 44: 313-323.
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K 2005 Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44: 40-50. *
Chapman RW 1995 The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon? Hepatology 21: 1473-1474.
Chapman RW 2003 Viruses, protozoans and drugs as etiological factors in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 73-74. October 15-16. *
Chassin C, Hornef MW, Bens M, Lotz M, Goujon JM, Vimont S, Arlet G, Hertig A, Rondeau E, Vandewalle A 2007 Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J. Exp. Med. 204: 2837-2852. *
Chen A, Liu S, Park D, Kang Y, Zheng G 2007 Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer. Cancer Res. 67: 1291-1298. *
Chen J, Wang Y, Kunkel G, Zhao H, Xue H, Xie X, Li L, Xu C, Shen L, Gu L 2005 Use of CD34(+) autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus. Clin. Rheumatol. 24: 464-468. *
Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ 2006 Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors. Crit. Care Med. 34: 1758-1768.
Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM 2006 Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203: 837-842. *
Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY 2007 Renal histology in Chinese patients with anti-myeloperoxidase autoantibodies positive Wegener's granulomatosis. Nephrol. Dial. Transplant. 22: 139-145.
Chen M, Yu F, Zhang Y, Zhao MH 2005 Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad. Med. J. 81: 723-727. *
Chen M, Yu F, Zhang Y, Zhao MH 2005 An analysis of multi-system involvement and renal pathology of anti-neutrophil cytoplasmic autoantibodies-related vasculitis. Zhonghua Nei Ke Za Zhi 44: 828-831.
Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY 2005 Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int. 68: 2225-2229.
Chen M, Zhao M, Zhang Y, Wang H 2002 Antigens of antineutrophil cytoplasmic autoantibodies in recognizing a novel neutrophil granule antigen in lupus nephritis and its association with photosensitivity and oral ulceration. Zhonghua Nei Ke Za Zhi 41: 766-768.
Chen M, Zhao MH, Zhang YK, Wang HY 2005 Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules. Nephrology (Carlton) 10: 491-495. *
Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H 2008 A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121: 1484-1490. *
Chiang N, Arita M, Serhan CN 2005 Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 73: 163-177. *
Chiappini E, Taccetti G, Campana S, Turchini S, Marianelli L 2001 Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization. Pediatr. Med. Chir. 23: 27-30.
Chikazawa H, Nishiya K, Matsumori A, Hashimoto K 2000 Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J. Clin. Immunol. 20: 279-286. *
Chilton FH, Patel M, Fonteh AN, Hubbard WC, Triggiani M 1993 Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. J. Clin. Invest. 91: 115-122. *
Chiriac M, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C 2007 NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J. Pathol. 212: 56-65. *
Chiron R, Grumbach YY, Quynh NV, Verriere V, Urbach V 2008 Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy. J. Cyst. Fibros. Jun 7 [Epub ahead of print].
Cho WS, Chae C 2004 Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium. Vet. Pathol. 41: 419-423. *
Cho WS, Choi M, Han BS, Cho M, Oh J, Park K, Kim SJ, Kim SH, Jeong J 2007 Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol. Lett. 175: 24-33. *
Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL 2001 Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J. Rheumatol. 28: 1584-1590.
Choi S, Choi HH, Lee SH, Ko SH, You HJ, Ye SK, Chung MH 2007 Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice. Free Radic. Biol. Med. 43: 1594-1603.
Chowdhary VR, Grande JP, Luthra HS, David CS 2007 Characterization of haemorrhagic pulmonary capillaritis: another manifestation of pristane-induced lupus. Rheumatology (Oxford) 46: 1405-1410. *
Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A 2006 The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12: 636-641. *
Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH 2006 Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee. J. Rheumatol. 33: 311-317.
Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R 1996 Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver 16: 28-34.
Clatworthy MR, Jayne DR 2006 Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab. Am. J. Kidney Dis. 47: 680-682.
Cohran VC, Heubi JE 2003 Treatment of pediatric cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 403-415.
Cojocaru IM, Cojocaru M, Burcin C 2007 Ischemic stroke accompanied by anti-PR3 antibody-related cerebral vasculitis and hepatitis C virus infection. Rom. J. Intern. Med. 45: 47-50.
Cojocaru M, Cojocaru IM, Iacob SA 2006 Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia. Rom. J. Intern. Med. 44: 427-431.
Colombel JF, Reumaux D, Duthilleul P, Noel LH, Gower-Rousseau C, Paris JC, Cortot A 1992 Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 16: 656-660.
Colvin RB, Smith RN 2005 Antibody-mediated organ-allograft rejection. Nat. Rev. Immunol. 5: 807-817. *
Conrad K, Schmechta H, Klafki A, Lobeck G, Uhlig HH, Gerdi S, Henker J 2002 Serological differentiation of inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 14: 129-135.
Cook HT, Botto M 2006 Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 330-337. *
Cooke A 2006 Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 3: 72-75. *
Cooley J, McDonald B, Accurso FJ, Crouch EC, Remold-O'Donnell E 2008 Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease. J. Leukoc. Biol. 83: 946-955. *
Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight KR, Daskalakis M, Doery JC 2000 Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol. Int. 19: 129-136. *
Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P 2001 Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment. Pharmacol. Ther. 15: 463-473.
Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B 2007 Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109: 2806-2814. *
Covic A, Mutica C, Ignat A, Boaru I, Veisa G, Gusbeth-Tatomir P, Enea M, Covic M 2004 Retrospective study of 97 ANCA-positive patients: epidemiological and clinical spectrum. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 305-310.
Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER 2008 Advances in neutrophil biology: clinical implications. Chest 134: 606-612. *
Cristea A, Badea T, Bodizs G, Olinic N 1995 Antineutrophil cytoplasmic autoantibodies (ANCA) - markers in diagnosis and monitoring systemic vasculitides. Rom. J. Intern. Med. 33: 37-46.
Cross A, Moots RJ, Edwards SW 2008 The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood 111: 878-884. *
Csernok E, Ahlquist D, Ullrich S, Gross WL 2002 A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 41: 1313-1317. *
Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J 1996 Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin. Exp. Immunol. 105: 104-111. *
Cuadrado A, Aresti S, Cortes MA, Gomez-Ortega JM, Salcines JR 2008 Autoimmune hepatitis and agranulocytosis. Dig. Liver Dis. Feb 26 [Epub ahead of print].
Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, Mohan C, Nachman PH, Clarke SH 2007 Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J. Clin. Immunol. 27: 53-68. *
Cunliffe RN 2003 alpha-Defensins in the gastrointestinal tract. Mol. Immunol. 40: 463-467. *
Cunliffe RN, Kamal M, Rose FR, James PD, Mahida YR 2002 Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J. Clin. Pathol. 55: 298-304. *
Cuvelier C, Mielants H, De Vos M, Quatacker J, Veys E 1994 Idiopathic inflammatory bowel diseases: immunological hypothesis. Acta Gastroenterol. Belg. 57: 292-299.
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP 2004 WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22: 340-346. *
Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C 2003 Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br. J. Pharmacol. 140: 366-376. *
Czaja AJ 2001 Autoimmune liver disease. Curr. Opin. Gastroenterol. 17: 268-275.
Czaja AJ 2007 Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80.
Czaja AJ 2006 Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55.
Czaja AJ 2005 Autoantibodies in autoimmune liver disease. Adv. Clin. Chem. 40: 127-164.
Czaja AJ 2000 Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270.
Czaja AJ 2004 Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240.
Czaja AJ 2004 Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54. *
Czaja AJ, Norman GL 2003 Autoantibodies in the diagnosis and management of liver disease. J. Clin. Gastroenterol. 37: 315-329.
Czaja AJ, Shums Z, Donaldson PT, Norman GL 2004 Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis. Dig. Dis. Sci. 49: 611-618. *
D'Acquisto F, Paschalidis N, Sampaio AL, Merghani A, Flower RJ, Perretti M 2007 Impaired T cell activation and increased Th2 lineage commitment in annexin-1-deficient T cells. Eur. J. Immunol. 37: 3131-3142. *
Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T 2004 Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874. *
da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho EG, de Sena MG, de Messias Reason IJ 2001 Spectrum of autoantibodies in celiac patients and relatives. Dig. Dis. Sci. 46: 2624-2630. *
da Rosa Utiyama SR, Nisihara RM, Nass FR, Oliveira NP, Fiedler PT, de Messias-Reason IT 2008 Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases? J. Paediatr. Child. Health 44: 182-186.
Dain L, Braun-Moscovici Y, Baum E, Nahir AM, Hoffer E 2006 Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab. Clin. Exp. Rheumatol. 24: 38-44.
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K 2006 The Severe Chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther. 3: 220-231.
Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM 1993 Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34: 658-664. *
Dalekos GN, Zachou K, Liaskos C, Gatselis N 2002 Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur. J. Intern. Med. 13: 293-303.
Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, Forget PP, Tervaert JW 2002 Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J. Clin. Immunol. 22: 281-288. *
Das KM 2004 Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294. *
Dassopoulos T 2001 Diagnostic methodologies: serology, endoscopy, and radiology. Curr. Gastroenterol. Rep. 3: 491-499.
David A, Fridlich R, Aviram I 2005 The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp. Cell Res. 308: 156-165. *
Davis MK, Andres JM, Jolley CD, Novak DA, Haafiz AB, Gonzalez-Peralta RP 2007 Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 45: 409-413.
Davis SD, Fordham LA, Brody AS, Noah TL, Retsch-Bogart GZ, Qaqish BF, Yankaskas BC, Johnson RC, Leigh MW 2007 Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am. J. Respir. Crit. Care Med. 175: 943-950. *
Day MJ 2008 Canine sino-nasal aspergillosis: parallels with human disease. Med. Mycol. Jun 26 [Epub ahead of print]. *
de Kozak Y, Omri B, Smith JR, Naud MC, Thillaye-Goldenberg B, Crisanti P 2007 Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13. Am. J. Pathol. 170: 1241-1257. *
De Rose V, Arduino C, Cappello N, Piana R, Salmin P, Bardessono M, Goia M, Padoan R, Bignamini E, Costantini D, Pizzamiglio G, Bennato V, Colombo C, Giunta A, Piazza A 2005 Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. Eur. J. Hum. Genet. 13: 96-101. *
De Vita S, Quartuccio L, Fabris M 2007 Rituximab in mixed cryoglobulinemia: increased experience and perspectives. Dig. Liver Dis. 39 Suppl. 1: S122-S128.
De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T, Iyer S 2005 Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J. Invest. Dermatol. 125: 473-481. *
Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, Assael BM, Mettey Y, Borgatti M, Mancini I, Gambari R, Becq F, Cabrini G 2007 MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am. J. Respir. Cell. Mol. Biol. 36: 615-624. *
Deleuran B, Abraham DJ 2007 Possible implication of the effector CD4(+) T-cell subpopulation T(H)17 in the pathogenesis of systemic scleroderma. Nat. Clin. Pract. Rheumatol. 3: 682-683. *
Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, Lamorte W, Farraye FA 2006 Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J. Gastrointest. Surg. 10: 1060-1064.
Denissen NH, Peters JG, Masereeuw R, Barrera P 2008 Can sulfasalazine therapy induce or exacerbate Wegener's granulomatosis? Scand. J. Rheumatol. 37: 72-74.
Der G, Love T, Schreck J, Horn M 2005 Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16. *
Desai HG, Gupte PA 2005 Increasing incidence of Crohn's disease in India: is it related to improved sanitation? Indian J. Gastroenterol. 24: 23-24. *
Desai SN, White DM, O'shea KM, Brown ML, Cywin CL, Spero DM, Panzenbeck MJ 2006 An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity. Eur. J. Pharmacol. 538: 168-174. *
Descamps FJ, Kangave D, Cauwe B, Martens E, Geboes K, El-Asrar AA, Opdenakker G 2008 Interphotoreceptor retinoid binding protein as biomarker in systemic autoimmunity with eye inflictions. J. Cell. Mol. Med. Feb 4 [Epub ahead of print]. *
Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG 2004 Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 139-146. *
Desplat-Jego S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, Ballot E, Sarles J, Baudon JJ, Grimaud JC, Veyrac M, Chamouard P, Humbel RL 2007 Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases � World J. Gastroenterol. 13: 2312-2318. *
Deveci F, Muz MH, Ilhan N, Kirkil G, Turgut T, Akpolat N 2008 Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology 13: 488-497.
DiMagno MJ, Lee SH, Hao Y, Zhou Sy, McKenna BJ, Owyang C 2005 A proinflammatory, anti-apoptotic phenotype underlies the susceptibility to acute pancreatitis in UNC cftr (-/-) mice. Gastroenterology 129: 665-681. *
Dinant S, Vetelainen RL, Florquin S, van Vliet AK, van Gulik TM 2007 IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J. Surg. Res. 141: 176-182.
Dinarello CA 2005 Anti-cytokine therapy from the bench to the bedside. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 84-86. *
Ding Y, Zhao L, Mei H, Zhang SL, Huang ZH, Duan YY, Ye P 2008 Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol. 590: 377-386.
Dini V, Romanelli M, Bertone M, Talarico S, Bombardieri S, Barachini P 2007 Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Int. J. Low Extrem. Wounds. 6: 108-113.
Diosdado B, van Bakel H, Strengman E, Franke L, van Oort E, Mulder CJ, Wijmenga C, Wapenaar MC 2007 Neutrophil recruitment and barrier impairment in celiac disease: a genomic study. Clin. Gastroenterol. Hepatol. 5: 574-581.e5.
Dold S, Laschke MW, Lavasani S, Menger MD, Thorlacius H 2008 Cholestatic liver damage is mediated by lymphocyte function antigen-1-dependent recruitment of leukocytes. Surgery 144: 385-393.
Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN 2008 Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112: 848-855. *
Donnelly S, Roake W, Brown S, Young P, Naik H, Wordsworth P, Isenberg DA, Reid KB, Eggleton P 2006 Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 54: 1543-1556. *
Donner MG, Schumacher S, Warskulat U, Heinemann J, Haussinger D 2007 Obstructive cholestasis induces TNF-alpha- and IL-1beta-mediated periportal down-regulation of Bsep and zonal regulation of Ntcp, Oatp1a4 and Oatp1b2. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1134-G1146. *
Doring G, Krogh-Johansen H, Weidinger S, Hoiby N 1994 Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr. Pulmonol. 18: 3-7.
Dorlochter L, Carlsson M, Olafsdottir EJ, Roksund OD, Rosendahl K, Fluge G 2004 Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J. Cyst. Fibros. 3: 179-183.
Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, Starcher B, Edgar J, Bilton D, Elborn JS 2007 The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr. Pulmonol. 42: 216-220.
Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, et al 2008 Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin. Gastroenterol. Hepatol. Jul 9 [Epub ahead of print].
Duerr RH, Neigut DA 1995 Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108: 423-427. *
Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F 1991 Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100: 1385-1391.
Dunn AC, Walmsley RS, Dedrick RL, Wakefield AJ, Lockwood CM 1999 Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain. J. Infect. 39: 81-87.
Dupont PJ, Warrens AN 2007 Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 120: 133-139. *
Durand V, Pers JO, Renaudineau Y, Saraux A, Youinou P, Jamin C 2001 Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function. J. Leukoc. Biol. 69: 233-240. *
Dusunceli F, Iseri SO, Ercan F, Gedik N, Yegen C, Yegen BC 2008 Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides 29: 1216-1222. *
Duymaz-Tozkir J, Yilmaz V, Uyar FA, Hajeer AH, Saruhan-Direskeneli G, Gul A 2005 Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behcet's disease. J. Rheumatol. 32: 93-97.
Dziarski R, Platt KA, Gelius E, Steiner H, Gupta D 2003 Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice. Blood 102: 689-697. *
Eckmann L 2005 Defence molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 21: 147-151.
Efthimiou J, Spickett G, Lane D, Thompson A 1991 Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet 337: 1037-1038.
Eggena M, Cohavy O, Parseghian MH, Hamkalo BA, Clemens D, Targan SR, Gordon LK, Braun J 2000 Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J. Autoimmun. 14: 83-97.
Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J 1996 Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J. Immunol. 156: 4005-4011.
Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH 2007 Immune-mediated liver injury. Semin. Liver Dis. 27: 351-366.
El Kebir D, Jozsef L, Khreiss T, Pan W, Petasis NA, Serhan CN, Filep JG 2007 Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 179: 616-622. *
Elezoglou A, Kafasi N, Kaklamanis PH, Theodossiadis PG, Kapsimali V, Choremi E, Vaiopoulos G, Sfikakis PP 2007 Infliximab treatment-induced formation of autoantibodies is common in Behcet's disease. Clin. Exp. Rheumatol. 25: S65-S69.
Elias E 2004 Hepatology highlights. Hepatology 39: 1467-1468. *
Elitsur Y, Lawrence Z, Tolaymat N 2005 The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience. J. Clin. Gastroenterol. 39: 670-673.
Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D 1998 Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am. J. Med. 105: 484-487. *
Elkayam O, Yaron M, Caspi D 1999 Minocycline-induced autoimmune syndromes: an overview. Semin. Arthritis Rheum. 28: 392-397.
Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BM, von dem Borne AE, Meuwissen SG, Goldschmeding R 1994 Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J. Clin. Pathol. 47: 257-262. *
Elloumi HZ, Holland SM 2008 Complex regulation of human cathelicidin gene expression: novel splice variants and 5'UTR negative regulatory element. Mol. Immunol. 45: 204-217.
Elzouki AN, Eriksson S, Lofberg R, Nassberger L, Wieslander J, Lindgren S 1999 The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm. Bowel Dis. 5: 246-252. *
Elzouki AN, Segelmark M, Wieslander J, Eriksson S 1994 Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J. Intern. Med. 236: 543-548.
Emmi L, Chatzipetrou A 2005 Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen. Ann. Ital. Med. Int. 20: 205-208. *
Ensari A, Ager A, Marsh MN, Morgan S, Moriarty KJ 1993 Time-course of adhesion molecule expression in rectal mucosa of gluten-sensitive subjects after gluten challenge. Clin. Exp. Immunol. 92: 303-307. *
Ensari A, Marsh MN, Loft DE, Morgan S, Moriarty K 1993 Morphometric analysis of intestinal mucosa. V. Quantitative histological and immunocytochemical studies of rectal mucosae in gluten sensitivity. Gut 34: 1225-1229. *
Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K, Doganay S 2002 Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br. J. Ophthalmol. 86: 653-657. *
Eriksson P 2005 Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J. Intern. Med. 257: 540-548. *
Esber EJ, Ferguson DR 1994 Primary sclerosing cholangitis. Gastroenterologist 2: 131-146.
Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboue R, Martin JP, Lesavre P 1993 Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 43: 1329-1332.
Esters N, Vermeire S, Joossens S, Noman M, Louis E, Belaiche J, De Vos M, Van Gossum A, Pescatore P, Fiasse R, Pelckmans P, Reynaert H, Poulain D, Bossuyt X, Rutgeerts P; Belgian Group of Infliximab Expanded Access Program in Crohn's Disease 2002 Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am. J. Gastroenterol. 97: 1458-1462. *
Facchinetti F, Amadei F, Geppetti P, Tarantini F, Di Serio C, Dragotto A, Gigli PM, Catinella S, Civelli M, Patacchini R 2007 Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell. Mol. Biol. 37: 617-623. *
Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y 2007 Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 45: 414-420.
Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ 2007 A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J. Invest. Dermatol. 127: 2605-2611. *
Fairweather D, Frisancho-Kiss S, Rose NR 2008 Sex differences in autoimmune disease from a pathological perspective. Am. J. Pathol. 173: 600-609. *
Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ 2001 Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J. Biol. Chem. 276: 49077-49082. *
Fararjeh M, Mohammad MK, Bustanji Y, Alkhatib H, Abdalla S 2008 Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes. Int. Immunopharmacol. 8: 341-350.
Faurschou M, Hasselbalch HC, Nielsen OJ 2001 Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia. Eur. J. Haematol. 66: 408-411. *
Fauzi AR, Kong NC, Chua MK, Jeyabalan V, Idris MN, Azizah R 2004 Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med. J. Malaysia 59: 372-377.
Favalli EG, Varenna M, Sinigaglia L 2005 Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin. Exp. Rheumatol. 23: 247-250.
Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V 2007 Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 27: 1064-1071.
Feldmann M, Pusey CD 2006 Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases. J. Am. Soc. Nephrol. 17: 1243-1252.
Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A 2006 NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093. *
Ferguson CA 2005 Disease models of autoimmunity. Trends Immunol. 26: 557-558. *
Fernandez-Flores A 2008 Dendritic cell component in fetal dermatitis. Rom. J. Morphol. Embryol. 49: 81-84.
Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M 2006 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130: 465-481. *
Figueiredo RT, Fernandez PL, Morao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graca-Souza AV, Bozza MT 2007 Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282: 20221-20229. *
Finnegan MJ, Hinchcliffe J, Russell-Jones D, Neill S, Sheffield E, Jayne D, Wise A, Hodson ME 1989 Vasculitis complicating cystic fibrosis. Q. J. Med. 72: 609-621.
Finucane FM, O'Connell J, Kinsley BT 2008 Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy. Ir. J. Med. Sci. 177: 69-71.
Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP 2008 Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin. Immunol. 128: 66-74. *
Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S 2008 Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin. Gastroenterol. Hepatol. 6: 561-568.
Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, Targan SR 2001 High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 49: 671-677. *
Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J 2003 Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853. *
Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J 2004 Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 50: 1286-1295. *
Folwaczny C, Jochum M, Noehl N, Schnettler D, Loeschke K, Fricke H 1998 p-ANCA target antigens in ulcerative colitis. Z. Gastroenterol. 36: 625-633.
Folwaczny C, Noehl N, Endres SP, Loeschke K, Fricke H 1998 Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand. J. Gastroenterol. 33: 523-528. *
Folwaczny C, Zahn R, Brunnler G, Albert E, Koenig A, Noehl N, Loeschke K, Fricke H 1999 Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis. Z. Gastroenterol. 37: 133-140.
Forde AM, Feighery C, Jackson J 1996 Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin. Immunol. Immunopathol. 81: 88-95. *
Forde AM, Feighery C, Jackson J 1998 Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniques. Br. J. Biomed. Sci. 55: 247-252.
Fortun PJ, Hawkey CJ 2005 Nonsteroidal antiinflammatory drugs and the small intestine. Curr. Opin. Gastroenterol. 21: 169-175.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S 1996 T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603. *
Franco J, Saeian K 1999 Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101.
Frangolias DD, Ruan J, Wilcox PJ, Davidson AG, Wong LT, Berthiaume Y, Hennessey R, Freitag A, Pedder L, Corey M, Sweezey N, Zielenski J, Tullis E, Sandford AJ 2003 Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. Am. J. Respir. Cell. Mol. Biol. 29: 390-396. *
Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK 2006 Update in the diagnosis and management of pulmonary vasculitis. Chest 129: 452-465. *
Frankenstein Z, Alon U, Cohen IR 2006 The immune-body cytokine network defines a social architecture of cell interactions. Biol. Direct 1: 32. *
Franssen CF, Hoorntje SJ, Kallenberg CG, Gans RO 1996 The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases. Ned. Tijdschr. Geneeskd. 140: 2076-2082.
Freeman H, Roeck B, Devine D, Carter C 1997 Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Can. J. Gastroenterol. 11: 203-207.
Freeman HJ 2000 Inflammatory bowel diseases in Indo-Canadians with and without antineutrophil cytoplasmic autoantibodies. Can. J. Gastroenterol. 14: 21-26.
Freeman HJ 1997 Atypical perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease. Can. J. Gastroenterol. 11: 689-693.
Freeman HJ 1998 Inflammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis. Can. J. Gastroenterol. 12: 279-282.
Freeman HJ 1997 Perinuclear antineutrophil cytoplasmic antibodies in collagenous or lymphocytic colitis with or without celiac disease. Can. J. Gastroenterol. 11: 417-420.
Freeman HJ, Roeck B, Devine DV, Carter CJ 1997 Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease. Can. J. Gastroenterol. 11: 305-310.
Frenzer A, Fierz W, Rundler E, Hammer B, Binek J 1998 Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 13: 950-954.
Fu HL, Hsu TC, Chang CC, Tsay GJ 2001 Antigenic specificity of anti-neutrophil cytoplasmic antibody. J. Formos. Med. Assoc. 100: 35-39.
Fujiwara M, Hirose K, Kagami S, Takatori H, Wakashin H, Tamachi T, Watanabe N, Saito Y, Iwamoto I, Nakajima H 2007 T-bet inhibits both T(H)2 cell-mediated eosinophil recruitment and T(H)17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 119: 662-670.
Furuta R, Ando T, Watanabe O, Maeda O, Ishiguro K, Ina K, Kusugami K, Goto H 2007 Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis. J. Gastroenterol. Hepatol. 22: 261-267. *
Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, Clancy J 2007 Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L96-L104. *
Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A 2006 Autoinflammatory syndromes. Clin. Exp. Rheumatol. 24: S79-S85.
Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon Garrido E, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J 1998 Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin. Exp. Rheumatol. 16: 541-546.
Gao X, Hu PJ, He Y, Liao SY, Peng S, Chen MH 2005 Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Zhonghua Nei Ke Za Zhi 44: 428-430.
Garcia Herola A, Nos P, Hinijosa J, Hoyos M, Moles J, Carmona E, Puig N, Sanchez-Cuenca J, Ponce J, Berenguer J 2003 HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease. Rev. Esp. Enferm. Dig. 95: 755-759.
Garcia-Herola A, Nos P, Hoyos M, Hinojosa J, Moles JR, Pascual S, Bustamante M, Sanchez Cuenca JM, Carmona E, Ponce J, Berenguer J 1998 Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease. Gastroenterol. Hepatol. 21: 169-173.
Garg N, Weinstock-Guttman B, Bhasi K, Locke J, Ramanathan M 2007 An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis. Mult. Scler. 13: 895-899.
Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B 2007 Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J. Neuroimmunol. 187: 159-165.
Gaspar C, Leyral C, Orlandini V, Begueret H, Pellegrin JL, Doutre MS, Beylot-Barry M 2008 Lethal pulmonary involvement of neutrophilic dermatosis following erythropoietin therapy. Ann. Dermatol. Venereol. 135: 384-388.
Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP 2008 Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology 149: 3403-3409. *
Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP 2006 Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Neuroimmunomodulation 13: 114-121.
Ge X, Uzunel M, Ericzon BG, Sumitran-Holgersson S 2005 Biliary epithelial cell antibodies induce expression of Toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis? Liver Transpl. 11: 911-921. *
Geboes K 1994 From inflammation to lesion. Acta Gastroenterol. Belg. 57: 273-284.
Geboes K, De Hertogh G 2003 Indeterminate colitis. Inflamm. Bowel Dis. 9: 324-331. *
Geffriaud-Ricouard C, Noel LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P 1993 Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol. 39: 125-136.
Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, Tracy TF Jr, Gregory SH 2006 Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 130: 810-822. *
Gekara NO, Weiss S 2008 Mast cells initiate early anti-Listeria host defences. Cell. Microbiol. 10: 225-236. *
Gencik M, Meller S, Borgmann S, Fricke H 2000 Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int. 58: 2473-2477. *
Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, Epplen JT 2000 The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin. Immunol. 94: 9-12. *
Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomeli D, Calignano A, Cuzzocrea S 2008 Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J. Pharmacol. Exp. Ther. 326: 12-23. *
Ghnaya H, Bekov K, Jira M, Kettaneh A, Mejri O, Tiev KP, Gain M, Cabane J 2008 Primary chronic autoimmune neutropenia successfully treated with sirolimus. Rev. Med. Interne. Apr 7 [Epub ahead of print].
Ghonaim M, Al-Ghamdi A, El-Bana H, Bakr A, Ghoneim E, El-Edel R, Hassona M, Shoeib S, Allam H 2005 Autoantibodies in chronic liver disease. Egypt. J. Immunol. 12: 101-111.
Ghoreschi K, Rocken M 2003 Immunopathogenesis of psoriasis. J. Dtsch. Dermatol. Ges. 1: 524-532.
Giamarellos-Bourboulis EJ 2008 Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int. J. Antimicrob. Agents 31: 12-20.
Gibson A, Stamp LK, Chapman PT, O'donnell JL 2006 The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 45: 624-628. *
Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW 2007 Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr. Pulmonol. 42: 610-623.
Giesemann T, Guttenberg G, Aktories K 2008 Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology 134: 2049-2058. *
Gigase P, De Clerck LS, Van Cotthem KA, Bridts CH, Stevens WJ, Van Outryve M, Pelckmans PA 1997 Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies. Dig. Dis. Sci. 42: 2171-2174. *
Giraldo E, Hinchado MD, Garcia JJ, Ortega E 2008 Influence of gender and oral contraceptives intake on innate and inflammatory response. Role of neuroendocrine factors. Mol. Cell. Biochem. 313: 147-153. *
Gisbert JP, Luna M, Legido J, Hermida C, Mate J, Pajares JM 2004 Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease. Med. Clin. (Barc.) 122: 134-135.
Godinez I, Haneda T, Raffatellu M, George MD, Paixao TA, Rolan HG, Santos RL, Dandekar S, Tsolis RM, Baumler AJ 2008 T cells help to amplify inflammatory responses induced by Salmonella enterica serotype typhimurium in the intestinal mucosa. Infect. Immun. 76: 2008-2017. *
Goetz M, Lehr HA, Neurath MF, Galle PR, Orth T 2003 Long-term evaluation of a rat model of chronic cholangitis resembling human primary sclerosing cholangitis. Scand. J. Immunol. 58: 533-540. *
Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH 1996 Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 24: 699-705. *
Gomez GD, Balcazar JL 2008 A review on the interactions between gut microbiota and innate immunity of fish. FEMS Immunol. Med. Microbiol. 52: 145-154. *
Gordon JN, Sabatino AD, Macdonald TT 2005 The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr. Opin. Gastroenterol. 21: 431-437.
Gordon LK, Eggena M, Holland GN, Weisz JM, Braun J 1998 pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J. Clin. Immunol. 18: 264-271.
Gordon LK, Eggena M, Targan SR, Braun J 1999 Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. Invest. Ophthalmol. Vis. Sci. 40: 1250-1255. *
Gordon LK, Eggena M, Targan SR, Braun J 2000 Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin. Immunol. 94: 42-50. *
Gorson KC 2007 Vasculitic neuropathies: an update. Neurologist 13: 12-19.
Goto A, Mukai M, Notoya A, Kohno M 2005 Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report. Mod. Rheumatol. 15: 118-122.
Gowri Priya C, Rathinam S, Muthukkaruppan V 2008 Evidences for endotoxin as a causative factor for leptospiral uveitis in humans. Invest. Ophthalmol. Vis. Sci. Jul 24 [Epub ahead of print].
Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, Volta U 2006 Anti-Saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut 55: 296. *
Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U 2005 Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment. Pharmacol. Ther. 21: 881-887. *
Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP 2008 Identification of a potent, selective, and orally active leukotriene A4 hydrolase inhibitor with anti-inflammatory activity. J. Med. Chem. 51: 4150-4169.
Griffith ME, Pusey CD 1997 HLA genes in ANCA-associated vasculitides. Exp. Clin. Immunogenet. 14: 196-205.
Griga T, Tromm A, Muller KM, May B 2000 Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases. Eur. J. Gastroenterol. Hepatol. 12: 559-564.
Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J 2007 Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J. Immunol. 179: 3958-3965.
Grimm MC, Elsbury SK, Pavli P, Doe WF 1996 Interleukin 8: cells of origin in inflammatory bowel disease. Gut 38: 90-98. *
Grissell TV, Chang AB, Gibson PG 2007 Reduced Toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children. Pediatr. Pulmonol. 42: 380-385.
Gross WL 1995 Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum. Dis. Clin. North Am. 21: 987-1011.
Gross WL, Csernok E, Helmchen U 1995 Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 103: 81-97.
Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM 2006 Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55: 216-224. *
Guerrero M, Gall E, Tilahun E, Garon J 2001 Wegener's granulomatosis presenting as subglottic stenosis. J. Clin. Rheumatol. 7: 91-96.
Guhl G, Garc�a-Diez A 2008 Subcutaneous Sweet syndrome. Dermatol. Clin. 26: 541-551.
Guillevin L 2007 Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA). Presse. Med. 36: 843-844.
Guillevin L, Pagnoux C 2008 Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides. Isr. Med. Assoc. J. 10: 89-91. *
Guilpain P, Chanseaud Y, Tamby MC, Mahr A, Servettaz A, Guillevin L, Mouthon L 2005 Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides. Presse. Med. 34: 1013-1022.
Guilpain P, Mouthon L 2008 Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clin. Rev. Allergy Immunol. 35: 59-65.
Guma M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olive A 2003 Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J. Clin. Endocrinol. Metab. 88: 2141-2146. *
Gupta A, Derbes C, Sellin J 2005 Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an academic medical center. Inflamm. Bowel Dis. 11: 898-902. *
Gupta SK, Fitzgerald JF, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR 2004 Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm. Bowel Dis. 10: 240-244. *
Gur H, Shen G, Sutjita M, Terrberry J, Alosachie I, Barka N, Lin HC, Peter JB, Meroni PL, Kaplan M, et al 1995 Autoantibody profile of primary sclerosing cholangitis. Pathobiology 63: 76-82.
Guyot N, Butler MW, McNally P, Weldon S, Greene CM, Levine RL, O'Neill SJ, Taggart CC, McElvaney NG 2008 Elafin, an elastase specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. J. Biol. Chem. Sep 17 [Epub ahead of print]. *
Haagsma EB, Mulder AH, Gouw AS, Horst G, Meerman L, Slooff MJ, Kallenberg CG 1993 Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis. J. Hepatol. 19: 8-14.
Haas-Stapleton EJ, Lu Y, Hong S, Arita M, Favoreto S, Nigam S, Serhan CN, Agabian N 2007 Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS ONE 2: e1316. *
Habeeb MA, Rajalingam R, Dhar A, Kumar A, Sharma MP, Mehra NK 1997 HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis. Am. J. Gastroenterol. 92: